Your browser doesn't support javascript.
loading
Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial.
Stein, Eytan M; Fathi, Amir T; DiNardo, Courtney D; Pollyea, Daniel A; Roboz, Gail J; Collins, Robert; Sekeres, Mikkael A; Stone, Richard M; Attar, Eyal C; Frattini, Mark G; Tosolini, Alessandra; Xu, Qiang; See, Wendy L; MacBeth, Kyle J; de Botton, Stéphane; Tallman, Martin S; Kantarjian, Hagop M.
Afiliación
  • Stein EM; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA. Electronic address: steine@mskcc.org.
  • Fathi AT; Massachusetts General Hospital Cancer Center, Boston, MA, USA; Harvard Medical School, Boston, MA, USA.
  • DiNardo CD; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pollyea DA; Division of Hematology, University of Colorado School of Medicine, Aurora, CO, USA.
  • Roboz GJ; Weill Cornell Medical College, New York, NY, USA; New York Presbyterian Hospital, New York, NY, USA.
  • Collins R; University of Texas Southwestern Medical Center, Dallas, TX, USA.
  • Sekeres MA; Cleveland Clinic Taussig Cancer Institute, Cleveland, OH, USA.
  • Stone RM; Dana Farber Cancer Institute, Boston, MA, USA.
  • Attar EC; Agios Pharmaceuticals, Cambridge, MA, USA.
  • Frattini MG; Celgene, Summit, NJ, USA.
  • Tosolini A; Celgene, Summit, NJ, USA.
  • Xu Q; Celgene, Summit, NJ, USA.
  • See WL; Celgene, Summit, NJ, USA.
  • MacBeth KJ; Celgene, Summit, NJ, USA.
  • de Botton S; Département d'Hématologie et Département d'Innovation Thérapeutique, Gustave Roussy, Villejuif, France; Université Paris-Sud, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
  • Tallman MS; Memorial Sloan Kettering Cancer Center, New York, NY, USA; Weill Cornell Medical College, New York, NY, USA.
  • Kantarjian HM; Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Lancet Haematol ; 7(4): e309-e319, 2020 Apr.
Article en En | MEDLINE | ID: mdl-32145771

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Triazinas / Síndromes Mielodisplásicos / Inhibidores Enzimáticos / Aminopiridinas / Isocitrato Deshidrogenasa Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Idioma: En Revista: Lancet Haematol Año: 2020 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Triazinas / Síndromes Mielodisplásicos / Inhibidores Enzimáticos / Aminopiridinas / Isocitrato Deshidrogenasa Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies Idioma: En Revista: Lancet Haematol Año: 2020 Tipo del documento: Article